Efficacy and Safety of Exubera (Inhaled Insulin) Compared With Subcutaneous Human .Insulin Therapy in Adult Subjects With Type 1 Diabetes Mellitus: A Long-Term, Outpatient, Open-Label, Parallel-Group Comparative Trial.

Trial Profile

Efficacy and Safety of Exubera (Inhaled Insulin) Compared With Subcutaneous Human .Insulin Therapy in Adult Subjects With Type 1 Diabetes Mellitus: A Long-Term, Outpatient, Open-Label, Parallel-Group Comparative Trial.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 02 Feb 2010

At a glance

  • Drugs Insulin; Insulin
  • Indications Type 1 diabetes mellitus
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 09 Jun 2008 Status changed from in progress to discontinued, according to ClinicalTrials.gov. This trial was terminated for commercial reasons.
    • 19 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top